(Q53254912)

12 May 2018

title

Characteristics of progression of early age-related macular degeneration: the cardiovascular health and age-related maculopathy study. (English)

1 reference

12 May 2018

1 reference

5

1 reference

12 May 2018

author name string

Tikellis G

1

1 reference

12 May 2018

Robman LD

2

1 reference

12 May 2018

Dimitrov P

3

1 reference

12 May 2018

Nicolas C

4

1 reference

12 May 2018

Guymer RH

6

1 reference

12 May 2018

publication date

26 May 2006

1 reference

12 May 2018

published in

Eye

1 reference

12 May 2018

volume

21

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

169-176

1 reference

12 May 2018

The prevalence of age-related maculopathy: the visual impairment project

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

Seven year follow-up of age-related maculopathy in an elderly British population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

Methodology of the Cardiovascular Health and Age-Related Maculopathy (CHARM) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

Methods for a population-based study of eye disease: the Melbourne Visual Impairment Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

Vitamin E supplementation and cataract: randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

The VECAT study: methodology and statistical power for measurement of age-related macular features. Vitamin E, Cataract, and Age-related Maculopathy Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

Baseline ophthalmic findings in the vitamin E, cataract and age-related maculopathy (VECAT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

The Wisconsin age-related maculopathy grading system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

Smoking and age-related maculopathy. The Blue Mountains Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

7 January 2021

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

7 January 2021

Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

7 January 2021

Cigarette smoking and age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702151

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6702151

1 reference

12 May 2018

1 reference

12 May 2018